Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain
Bernardino Alcázar-Navarrete,1,2 Francisco García-Rio,2,3 Guadalupe Sánchez,4 Esther Mariscal,5 Andrea García,5 Maribel Cuesta,6 Estefany Uría,6 Marc Miravitlles2,7 1Respiratory Department. Hospital Universitario Virgen de las Nieves, Granada, Spain; 2CIBER de Enfermedades Respiratorias (CIBERES), M...
Main Authors: | Alcázar-Navarrete B, García-Rio F, Sánchez G, Mariscal E, García A, Cuesta M, Uría E, Miravitlles M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/burden-of-disease-among-exacerbating-patients-with-copd-treated-with-t-peer-reviewed-fulltext-article-COPD |
Similar Items
-
Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01) -
Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
by: Calverley PMA, et al.
Published: (2017-11-01) -
Burden of disease associated with a COPD eosinophilic phenotype
by: Ortega H, et al.
Published: (2018-08-01) -
The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
by: Miłkowska-Dymanowska J, et al.
Published: (2018-11-01) -
Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators
by: Lu FY, et al.
Published: (2021-02-01)